The DOI matches its Crossref record; 124 of the 124 references it cites were found in a registry or an index.
Drugs that modulate aging: the promising yet difficult path ahead
Open accessAbstract
Once a backwater in medical sciences, aging research has emerged and now threatens to take the forefront. This dramatic change of stature is driven from 3 major events. First and foremost, the world is rapidly getting old. Never before have we lived in a demographic environment like today, and the trends will continue such that 20% percent of the global population of 9 billion will be over the age of 60 by 2050. Given current trends of sharply increasing chronic disease incidence, economic disaster from the impending silver tsunami may be ahead. A second major driver on the rise is the dramatic progress that aging research has made using invertebrate models such as worms, flies, and yeast. Genetic approaches using these organisms have led to hundreds of aging genes and, perhaps surprisingly, strong evidence of evolutionary conservation among longevity pathways between disparate species, including mammals. Current studies suggest that this conservation may extend to humans. Finally, small molecules such as rapamycin and resveratrol have been identified that slow aging in model organisms, although only rapamycin to date impacts longevity in mice. The potential now exists to delay human aging, whether it is through known classes of small molecules or a plethora of emerging ones. But how can a drug that slows aging become approved and make it to market when aging is not defined as a disease. Here, we discuss the strategies to translate discoveries from aging research into drugs. Will aging research lead to novel therapies toward chronic disease, prevention of disease or be targeted directly at extending lifespan?
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Evidence amassed in recent years indicates that aging science shows great promise as a method of extending health span (50)(51)(52)(53)(54)(55)(56).”
From Inconvenient Truths About Human Longevity (2019) · cites this paper as [50]
In the citing paper
“A growing body of research has highlighted mTOR inhibitors, i.e., rapamycin and everolimus, as promising treatments for several age-related pathologies, including immunosenescence, prolonging lifespan, especially in all four major animal models of aging: yeast, worms, flies, and mice (204, 205).”
From Immunosenescence and Its Hallmarks: How to Oppose Aging Strategically? A Review of Potential Options for Therapeutic Intervention (2019) · cites this paper as [205]
In the citing paper
“A growing body of research has highlighted mTOR inhibitors, i.e., rapamycin and everolimus, as promising treatments for several age-related pathologies, including immunosenescence, prolonging lifespan, especially in all four major animal models of aging: yeast, worms, flies, and mice (204, 205).”
From Immunosenescence and Its Hallmarks: How to Oppose Aging Strategically? A Review of Potential Options for Therapeutic Intervention (2019) · cites this paper as [205]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
mTOR Signaling in Growth Control and Disease
Laplante, M., & Sabatini, D. M. (2012) · Cell · doi:10.1016/j.cell.2012.03.017 · Cited by 8,509
Pleiotropy, natural selection, and the evolution of senescence.
Williams, G. C. (1957) · Evolution · doi:10.1111/j.1558-5646.1957.tb02911.x · Cited by 4,279
Therapeutic potential of resveratrol: the in vivo evidence
Baur, J. A., & Sinclair, D. A. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2060 · Cited by 3,958
Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan
Howitz, K. T., Bitterman, K. J., Cohen, H. Y., Lamming, D. W., Lavu, S., Wood, J. G., Zipkin, R. E., Chung, P., Kisielewski, A., Zhang, L.-L., et al. (2003) · Nature · doi:10.1038/nature01960 · Cited by 3,796
Rapamycin fed late in life extends lifespan in genetically heterogeneous mice
Harrison, D. E., Strong, R., Sharp, Z. D., Nelson, J. F., Astle, C. M., Flurkey, K., Nadon, N. L., Wilkinson, J. E., Frenkel, K., Carter, C. S., et al. (2009) · Nature · doi:10.1038/nature08221 · Cited by 3,766
A C. elegans mutant that lives twice as long as wild type
Kenyon, C., Chang, J., Gensch, E., Rudner, A., & Tabtiang, R. (1993) · Nature · doi:10.1038/366461a0 · Cited by 3,387
Extending Healthy Life Span—From Yeast to Humans
Fontana, L., Partridge, L., & Longo, V. D. (2010) · Science · doi:10.1126/science.1172539 · Cited by 3,023
Kenyon, C. J. (2010) · Nature · doi:10.1038/nature08980 · Cited by 2,739
Prolonged Rapamycin Treatment Inhibits mTORC2 Assembly and Akt/PKB
Sarbassov, D. D., Ali, S. M., Sengupta, S., Sheen, J.-H., Hsu, P. P., Bagley, A. F., Markhard, A. L., & Sabatini, D. M. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.03.029 · Cited by 2,365
Kaeberlein, M., McVey, M., & Guarente, L. (1999) · Genes & Development · doi:10.1101/gad.13.19.2570 · Cited by 2,253 · cited 8×
“M AN US CR IP T AC CE PT ED Abbreviations: FDA = Food and Drug Administration; IGF = Insulin-like Growth Factor; SIR2 = Silent Information Regulator Two; IIS = Insulin/IGF Signaling; PKA = Protein Kinase A; mTOR = Mammalian Target Of Rapamycin; TORC1 = Target of Rapamycin Complex 1; TORC2 = Target of Rapamycin Complex…”
BackgroundInfluential
Cited by
Sorted by citations
Geroscience: Linking Aging to Chronic Disease
Kennedy, B. K., Berger, S. L., Brunet, A., Campisi, J., Cuervo, A. M., Epel, E. S., Franceschi, C., Lithgow, G. J., Morimoto, R. I., Pessin, J. E., et al. (2014) · Cell · doi:10.1016/j.cell.2014.10.039 · Cited by 2,764
Self-citationAiello, A., Farzaneh, F., Candore, G., Caruso, C., Davinelli, S., Gambino, C. M., Ligotti, M. E., Zareian, N., & Accardi, G. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02247 · Cited by 693
Interventions to slow aging in humans: are we ready?
Longo, V. D., Antebi, A., Bartke, A., Barzilai, N., Brown‐Borg, H. M., Caruso, C., Curiel, T. J., Cabo, R., Franceschi, C., Gems, D., et al. (2015) · Aging Cell · doi:10.1111/acel.12338 · Cited by 592
“Many of the interventions that extend lifespan in model organisms have the effect of reducing mTORC1 signaling (Johnson et al. , 2013; Kennedy & Pennypacker, 2014).”
Self-citationEssential role for autophagy in life span extension
Madeo, F., Zimmermann, A., Maiuri, M. C., & Kroemer, G. (2015) · Journal of Clinical Investigation · doi:10.1172/jci73946 · Cited by 464
Age-Related Change in Mobility: Perspectives From Life Course Epidemiology and Geroscience.
Ferrucci, L., Cooper, R., Shardell, M., Simonsick, E., Schrack, J., & Kuh, D. (2016) · The journals of gerontology. Series A, Biological sciences and medical sciences · doi:10.1093/gerona/glw043 · Cited by 386
Sirtuins: guardians of mammalian healthspan
Giblin, W., Skinner, M. E., & Lombard, D. B. (2014) · Trends in Genetics · doi:10.1016/j.tig.2014.04.007 · Cited by 286
Medical research: Treat ageing
Fontana, L., Kennedy, B. K., Longo, V. D., Seals, D. R., & Melov, S. (2014) · Nature · doi:10.1038/511405a · Cited by 271
Self-citationJin, K. (2014) · Aging and Disease · doi:10.14336/ad.2014.1210 · Cited by 232
The Business of Anti-Aging Science
de Magalhães, J. P., Stevens, M., & Thornton, D. (2017) · Trends in biotechnology · doi:10.1016/j.tibtech.2017.07.004 · Cited by 174
Anti-aging pharmacology: Promises and pitfalls
Vaiserman, A. M., Lushchak, O. V., & Koliada, A. K. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.08.004 · Cited by 148
Does Longer Lifespan Mean Longer Healthspan?
Hansen, M., & Kennedy, B. K. (2016) · Trends in Cell Biology · doi:10.1016/j.tcb.2016.05.002 · Cited by 134
Self-citationAntiaging agents: safe interventions to slow aging and healthy life span extension
Liu, J. (2022) · Natural Products and Bioprospecting · doi:10.1007/s13659-022-00339-y · Cited by 112
He, C. Z., Tsuchiyama, S. K., Nguyen, Q. T. T., Proshkina, E., Terrill, S. R., Sahibzada, S., Patel, B., Faulkner, A. R., Shaposhnikov, M. V., Tian, R., et al. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004860 · Cited by 97
Self-citationThe yeast replicative aging model
He, C. Z., Zhou, C., & Kennedy, B. K. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.02.023 · Cited by 95
Self-citationDAF-16 target identification in C. elegans: past, present and future
Tullet, J. M. A. (2014) · Biogerontology · doi:10.1007/s10522-014-9527-y · Cited by 90
Demidenko, O., Barardo, D., Budovskii, V., Finnemore, R., Palmer, F. R., Kennedy, B. K., & Budovskaya, Y. V. (2021) · Aging · doi:10.18632/aging.203736 · Cited by 80
Self-citationRosoff, D. B., Mavromatis, L. A., Bell, A. S., Wagner, J., Jung, J., Marioni, R. E., Smith, G. D., Horvath, S., & Lohoff, F. W. (2023) · Nature Aging · doi:10.1038/s43587-023-00455-5 · Cited by 89
Popovich, I. G., Anisimov, V. N., Zabezhinski, M. A., Semenchenko, A. V., Тындык, М. Л., Yurova, M. N., & Blagosklonny, M. V. (2014) · Cancer Biology & Therapy · doi:10.4161/cbt.28164 · Cited by 79
Translating the Science of Aging into Therapeutic Interventions
Kirkland, J. L. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a025908 · Cited by 78
Vaiserman, A. M., & Lushchak, O. V. (2017) · Journal of Translational Medicine · doi:10.1186/s12967-017-1259-8 · Cited by 72
Aging and Chronic Liver Disease
Maeso‐Díaz, R., & Gracia‐Sancho, J. (2020) · Seminars in Liver Disease · doi:10.1055/s-0040-1715446 · Cited by 71
Inconvenient Truths About Human Longevity
Olshansky, S. J., & Carnes, B. A. (2019) · The Journals of Gerontology: Series A · doi:10.1093/gerona/glz098 · Cited by 67
Hill, B. G., Shiva, S., Ballinger, S. W., Zhang, J., & Darley-Usmar, V. M. (2019) · Biological Chemistry · doi:10.1515/hsz-2019-0268 · Cited by 66
Zhavoronkov, A. A., Buzdin, A. A., Garazha, A., Borisov, N., & Moskalev, A. (2014) · Frontiers in Genetics · doi:10.3389/fgene.2014.00049 · Cited by 56
Targeting Autophagy with Natural Products as a Potential Therapeutic Approach for Cancer
Al‐Bari, M. A. A., Ito, Y., Ahmed, S. B. M., Radwan, N., Ahmed, H. S., & Eid, N. A. S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22189807 · Cited by 55
Metformin alleviates neurocognitive impairment in aging via activation of AMPK/BDNF/PI3K pathway
Ameen, O., Samaka, R. M., & Abo-Elsoud, R. A. A. (2022) · Scientific Reports · doi:10.1038/s41598-022-20945-7 · Cited by 55
Protective effect of atorvastatin on d-galactose-induced aging model in mice
Kaviani, E., Rahmani, M. R., Kaeidi, A., Shamsizadeh, A., Allahtavakoli, M., Mozafari, N., & Fatemi, I. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.07.029 · Cited by 55
Does eating less make you live longer and better? An update on calorie restriction
Picca, A., Pesce, V., & Lezza, A. M. S. (2017) · Clinical Interventions in Aging · doi:10.2147/cia.s126458 · Cited by 57
Ward, D. D., Wallace, L. M. K., & Rockwood, K. J. (2020) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2020-324081 · Cited by 53
Bytyçi, I., & Henein, M. Y. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10122670 · Cited by 52
Protective effect of metformin on D-galactose-induced aging model in mice.
Fatemi, I., Khaluoi, A., Kaeidi, A., Shamsizadeh, A., Heydari, S., & Allahtavakoli, M. (2018) · PubMed Central · doi:10.22038/ijbms.2017.24331.6071 · Cited by 49
Protective effect of walnut on d ‐galactose‐induced aging mouse model
Liu, J., Chen, D., Wang, Z., Chen, C., Ning, D., & Zhao, S. (2019) · Food Science & Nutrition · doi:10.1002/fsn3.907 · Cited by 46
Yao, Y., Tsuchiyama, S. K., Yang, C., Bulteau, A., He, C. Z., Robison, B., Tsuchiya, M., Miller, D. M., Briones, V., Tar, K., et al. (2015) · PLoS Genetics · doi:10.1371/journal.pgen.1004968 · Cited by 46
Self-citationSenescence: Pathogenic Driver in Chronic Obstructive Pulmonary Disease
Rivas, M., Gupta, G., Costanzo, L., Ahmed, H., Wyman, A. E., & Geraghty, P. M. (2022) · Medicina · doi:10.3390/medicina58060817 · Cited by 47
Rapamycin maintains NAD+/NADH redox homeostasis in muscle cells
Zhang, Z., Xu, H. N., Li, S., Dávila, A., Chellappa, K., Davis, J. G., Guan, Y., Frederick, D. W., Chu, W., Zhao, H., et al. (2020) · Aging · doi:10.18632/aging.103954 · Cited by 40
Tumor promoter-induced cellular senescence: cell cycle arrest followed by geroconversion
Leontieva, O. V., & Blagosklonny, M. V. (2014) · Oncotarget · doi:10.18632/oncotarget.3011 · Cited by 37
Healthy aging: A bibliometric analysis of the literature
Gu, Y., Bai, J., Chen, X., Wu, W., Liu, X., & Tan, X. (2018) · Experimental Gerontology · doi:10.1016/j.exger.2018.11.014 · Cited by 40
Aging research using the common marmoset: Focus on aging interventions
Ross, C. N., & Salmon, A. B. (2018) · Nutrition and Healthy Aging · doi:10.3233/nha-180046 · Cited by 35
Genetics and Pharmacology of Longevity
Castillo-Quan, J. I., Kinghorn, K. J., & Bjedov, I. (2015) · Advances in genetics · doi:10.1016/bs.adgen.2015.06.002 · Cited by 37
Interventions to slow cardiovascular aging: Dietary restriction, drugs and novel molecules
Heiß, C., Spyridopoulos, I., & Haendeler, J. (2017) · Experimental Gerontology · doi:10.1016/j.exger.2017.06.015 · Cited by 36
Antibiotics that target mitochondria extend lifespan in C. elegans
Bonuccelli, G., Brooks, D. R., Shepherd, S., Sotgia, F., & Lisanti, M. P. (2023) · Aging · doi:10.18632/aging.205229 · Cited by 35
Ross, C. N., Austad, S. N., Brasky, K., Brown, C. J., Forney, L. J., Gelfond, J., Lanford, R. E., Richardson, A. G., & Tardif, S. D. (2017) · Aging · doi:10.18632/aging.101340 · Cited by 32
Longevity-Promoting Pharmaceuticals: Is it a Time for Implementation?
Vaiserman, A. M., & Marotta, F. (2016) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2016.02.003 · Cited by 31
Mitochondria and the Repurposing of Diabetes Drugs for Off-Label Health Benefits
Yip, J., Chiang, G. S. H., Lee, I. C. J., Lehming-Teo, R., Dai, K., Dongol, L., Wang, L. Y.-T., Teo, D. W. X., Seah, G. T., & Lehming, N. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26010364 · Cited by 30
Balistreri, C. R. (2018) · Mediators of Inflammation · doi:10.1155/2018/3705389 · Cited by 31
Guo, D., Shen, Y., Li, W., Li, Q., Miao, Y., & Zhong, Y. (2020) · Aging · doi:10.18632/aging.102666 · Cited by 26
CD4+ T-Cell Senescence in Neurodegenerative Disease: Pathogenesis and Potential Therapeutic Targets
Gao, Y., Lu, Y., Liang, X., Zhao, M., Yu, X., Fu, H., & Yang, W. (2024) · Cells · doi:10.3390/cells13090749 · Cited by 27
Firdaus, Z., Singh, N., Prajapati, S. K., Krishnamurthy, S., & Singh, T. D. (2020) · Drug and Chemical Toxicology · doi:10.1080/01480545.2020.1833907 · Cited by 25
Gaspar, L. S., Sousa, C., Álvaro, A. R., Cavadas, C., & Mendes, A. F. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105369 · Cited by 24
Monoterpenes as Sirtuin-1 Activators: Therapeutic Potential in Aging and Related Diseases
Sousa, C., & Mendes, A. F. (2022) · Biomolecules · doi:10.3390/biom12070921 · Cited by 24
Olovnikov, A. M. (2015) · Current Aging Science · doi:10.2174/1874609808666150422114916 · Cited by 24
Atef, M. M., Emam, M. N., Gheit, R. E. A. E., El-Beltagi, E. M., Alshenawy, H. A., Radwan, D. A., Younis, R. L., & Abd‐Ellatif, R. N. (2022) · Neurochemical Research · doi:10.1007/s11064-022-03559-3 · Cited by 22
Emerging uncertainty on the anti-aging potential of metformin
Keys, M. T., Hallas, J., Miller, R. A., Suissa, S., & Christensen, K. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102817 · Cited by 24
Metformin ameliorates the age‐related changes of d ‐galactose administration in ovariectomized mice
Fatemi, I., Heydari, S., Kaeidi, A., Shamsizadeh, A., Hakimizadeh, E., Khaluoi, A., & Allahtavakoli, M. (2018) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.12364 · Cited by 21
The Role of SOX Transcription Factors in Ageing and Age-Related Diseases
Stevanović, M. J., Lazic, A., Schwirtlich, M., & Ninković, D. S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24010851 · Cited by 19
Varela‐López, A., Romero‐Márquez, J. M., Navarro‐Hortal, M. D., Ramírez-Tortosa, C. L., Battino, M. A., Forbes-Hernández, T. Y., & Quiles, J. L. (2023) · Experimental Gerontology · doi:10.1016/j.exger.2023.112221 · Cited by 22
Ross, C. N. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811829-0.00021-2 · Cited by 20
Nutrient Sensing and Redox Balance: GCN2 as a New Integrator in Aging
Falcón, P., Escandón, M., Brito, Á., & Matus, S. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/5730532 · Cited by 21
Six plant extracts delay yeast chronological aging through different signaling pathways
Lutchman, V., Dakik, P., McAuley, M., Cortes, B., Ferraye, G., Gontmacher, L., Graziano, D., Moukhariq, F.-Z., Simard, É., & Titorenko, V. I. (2016) · Oncotarget · doi:10.18632/oncotarget.10689 · Cited by 19
An essay on the nominal vs. real definitions of aging
Golubev, A. G. (2021) · Biogerontology · doi:10.1007/s10522-021-09926-x · Cited by 21
What is the evidence for stress resistance and slowed aging?
Hamilton, K. L., & Miller, B. F. (2016) · Experimental Gerontology · doi:10.1016/j.exger.2016.06.001 · Cited by 20
Hakimizadeh, E., Zamanian, M. Y., Borisov, V. V., Giménez‐Llort, L., Ehsani, V., Kaeidi, A., Hassanshahi, J., Khajehasani, F., Movahedinia, S., & Fatemi, I. (2022) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.12752 · Cited by 18
Guo, D., Shen, Y., Li, W., Li, Q., Zhao, Y., Pan, C., Chen, B., Zhong, Y., & Miao, Y. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00320 · Cited by 17
6-Bromoindirubin-3’-oxime (6BIO) prevents myocardium from aging by inducing autophagy
Guo, D., Cheng, L., Shen, Y., Li, W., Li, Q., Zhong, Y., & Miao, Y. (2020) · Aging · doi:10.18632/aging.202253 · Cited by 17
A Deep-Learning Proteomic-Scale Approach for Drug Design
Overhoff, B., Falls, Z., Mangione, W., & Samudrala, R. (2021) · Pharmaceuticals · doi:10.3390/ph14121277 · Cited by 16
Aging-modulating treatments: from reductionism to a system-oriented perspective
Vaiserman, A. M. (2014) · Frontiers in Genetics · doi:10.3389/fgene.2014.00446 · Cited by 16
Teo, E., Fong, S., Tolwinski, N. S., & Gruber, J. (2020) · GeroScience · doi:10.1007/s11357-020-00169-1 · Cited by 18
Resveratrol Modulates Mitochondria Dynamics in Replicative Senescent Yeast Cells
Wang, I.-H., Chen, H., Wang, Y., Chang, K., Chen, Y., & Chang, C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104345 · Cited by 15
Kennedy, B. K., & Pennypacker, J. K. (2015) · Oncotarget · doi:10.18632/oncotarget.3173 · Cited by 14
Self-citationTherapeutic Manipulation of Ageing: Repurposing Old Dogs and Discovering New Tricks
Mallikarjun, V., & Swift, J. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.11.020 · Cited by 14
Chen, H., Tang, H., Zhang, X., Huang, J., Luo, N., Guo, Q., & Wang, X. (2024) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2024.04.004 · Cited by 14
The TORC1 inhibitor Nprl2 protects age-related digestive function in Drosophila
Xi, J., Cai, J., Yang, C., Fu, Y., Wei, W., Zhang, Z., Zhuang, Z., Hao, Y., Lilly, M. A., & Wei, Y. (2019) · Aging · doi:10.18632/aging.102428 · Cited by 14
Krops, L. A., Bouma, A. J., van Nassau, F., Nauta, J., van den Akker‐Scheek, I., Bossers, W. J. R., Brügemann, J., Buffart, L. M., Diercks, R. L., de Groot, V., et al. (2020) · JMIR Research Protocols · doi:10.2196/19397 · Cited by 15
Gerosuppression in confluent cells
Leontieva, O. V., & Blagosklonny, M. V. (2014) · Aging · doi:10.18632/aging.100714 · Cited by 14
Singh, A. K., Peng, B., Chien, S.-T., Chan, C.-H., Deng, Y.-H., Pai, H., Wei, H.-J., Wang, M.-F., Wang, S., Wu, C.-Y., et al. (2023) · Biomaterials Science · doi:10.1039/d2bm01997c · Cited by 13
Birkisdóttir, M. B., van Galen, I., Brandt, R. M. C., Barnhoorn, S., van Vliet, N., van Dijk, C., Nagarajah, B., Imholz, S., van Oostrom, C. T., Reiling, E., et al. (2022) · Frontiers in Aging · doi:10.3389/fragi.2022.1005322 · Cited by 13
Chronic Mechanistic Target of Rapamycin Inhibition: Preventing Cancer to Delay Aging, or Vice Versa?
Sharp, Z. D., Curiel, T. J., & Livi, C. B. (2013) · Interdisciplinary topics in gerontology and geriatrics · doi:10.1159/000343625 · Cited by 11
mTOR inhibitors for treatment of low-risk prostate cancer
Liss, M. A., Rickborn, L., DiGiovanni, J., Bacich, D. J., deGraffenried, L. A., Parihar, M., Thompson, I. M., & Sharp, Z. D. (2018) · Medical Hypotheses · doi:10.1016/j.mehy.2018.06.004 · Cited by 12
Translational research on aging: clinical epidemiology as a bridge between the sciences
Callahan, C. M., Foroud, T., Saykin, A. J., Shekhar, A., & Hendrie, H. C. (2013) · Translational research · doi:10.1016/j.trsl.2013.09.002 · Cited by 13
Alpha-1 Antitrypsin Deficiency and Accelerated Aging: A New Model for an Old Disease?
Crossley, D., Stockley, R. A., & Sapey, E. (2019) · Drugs & Aging · doi:10.1007/s40266-019-00684-7 · Cited by 12
Dakik, P., Rodriguez, M. E. L., Junio, J. A. B., Mitrofanova, D., Medkour, Y., Tafakori, T., Taifour, T., Lutchman, V., Samson, E., Arlia‐Ciommo, A., et al. (2020) · Oncotarget · doi:10.18632/oncotarget.27615 · Cited by 10
Commentary: Life course epidemiology embraces geroscience
Ferrucci, L. (2016) · International Journal of Epidemiology · doi:10.1093/ije/dyw104 · Cited by 10
Park, M. S., Choi, J., Lee, W., Yang, Y. J., Kim, J., Lee, G.-J., Kim, S. S., Park, S. H., Kim, S. C., & Choi, J. W. (2015) · Oncotarget · doi:10.18632/oncotarget.3949 · Cited by 8
Motevalian, M., Maroof, N. T., Nematollahi, M. H., Khajehasani, F., & Fatemi, I. (2021) · PubMed Central · doi:10.22038/ijbms.2021.58502.12996 · Cited by 8
Longevity expectations in the pension fund, insurance, and employee benefits industries
Zhavoronkov, A. A. (2015) · Psychology Research and Behavior Management · doi:10.2147/prbm.s75440 · Cited by 8
Ji, J., Zhang, B., Zheng, J., Zhang, X., Hu, X., Zhu, H., Wang, P., & Lan, Z. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.119883 · Cited by 7
Design and Analysis of Pharmacological Studies in Aging
Clay, K. J., & Petrascheck, M. (2020) · Methods in molecular biology · doi:10.1007/978-1-0716-0592-9_7 · Cited by 7
Wong, L. P., Alias, H., Tan, K. M., Wong, P., Murugan, D. D., Hu, Z., & Lin, Y. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1254470 · Cited by 6
A Genetic Variant of ASCT2 Hampers In Vitro RNA Splicing and Correlates with Human Longevity
D’Aquila, P., Crocco, P., Rango, F. D., Indiveri, C., Bellizzi, D., Rose, G., & Passarino, G. (2017) · Rejuvenation Research · doi:10.1089/rej.2017.1948 · Cited by 6
Report: NIA workshop on translating genetic variants associated with longevity into drug targets
Participants, O. B. O. W. S. A., Schork, N. J., & Raghavachari, N. (2018) · GeroScience · doi:10.1007/s11357-018-0046-7 · Cited by 6
Chen, H., Tang, H., Zhang, X., Huang, J., Luo, N., Guo, Q., & Wang, X. (2024) · Revista Española de Cardiología · doi:10.1016/j.recesp.2024.04.004 · Cited by 5
An Introductory Guide to Using Bloomington Drosophila Stock Center and FlyBase for Aging Research
Zheng, X. (2024) · Cells · doi:10.3390/cells13141192 · Cited by 5
Gupta, V., Crudu, A., Matsuoka, Y., Ghosh, S., Rozot, R., Marat, X., Jäger, S., Kitano, H., & Breton, L. (2019) · npj Systems Biology and Applications · doi:10.1038/s41540-019-0119-y · Cited by 5
Potential of nanoparticles and nanopolymers in treatment of age-associated diseases
Saadatpour, F., Mohammadipanah, F., Zohourian, N., & Hodjat, M. (2021) · Advances in Natural Sciences Nanoscience and Nanotechnology · doi:10.1088/2043-6262/ac42c7 · Cited by 3
Participatory Exercise Medicine and Personalized Healthcare
Ren, S., & Shen, B. (2022) · Springer eBooks · doi:10.1007/978-981-16-9162-1_2 · Cited by 4
International Investment in Geroscience
Leng, S. X., & Kennedy, B. K. (2019) · Public Policy & Aging Report · doi:10.1093/ppar/prz024 · Cited by 4
Self-citationOlshansky, S. J. (2019) · Springer eBooks · doi:10.1007/978-3-319-69892-2_397-1 · Cited by 4
Living healthily to 120: Implications for entrepreneurship
van Gelderen, M. (2025) · Journal of Business Venturing · doi:10.1016/j.jbusvent.2025.106512 · Cited by 4
Umekar, M. J., Qutub, M., Premchandani, T., Tatode, A., Taksansde, J., Singanwad, P., Kale, M. B., Maniyar, M. G., & Hussain, U. (2025) · Precision medication. · doi:10.1016/j.prmedi.2025.100051 · Cited by 4
Assessing chronological aging in Saccharomyces cerevisiae
Schulze, A., Zimmermann, A., Kainz, K., Egger, N. B., Bauer, M. A., Madeo, F., & Carmona‐Gutiérrez, D. (2023) · Methods in cell biology · doi:10.1016/bs.mcb.2022.09.006 · Cited by 3
Metadata
- Authors
- Kennedy, B. K., & Pennypacker, J. K.
- Affiliations
- Buck Institute for Research on Aging (US)
- Corresponding author
- Kennedy, Brian K.
- ORCID
- Kennedy, Brian K.
- Venue
- Translational research
- Publisher
- Elsevier BV
- Published
- 2014-05
- Volume
- 163
- Issue
- 5
- Pages
- 456-465
- ISSN
- 1878-1810 (ISSN-L)
- 1931-5244
- PMC
- PMC4004650
- OpenAlex
- W2111463058
- Cited by
- 127
- References
- 123
- Citations by year
- 2026: 1 · 2025: 10 · 2024: 5 · 2023: 8 · 2022: 10 · 2021: 8 · 2020: 14 · 2019: 15 · 2018: 10 · 2017: 8 · 2016: 11 · 2015: 12 · 2014: 13
- FWCI
- 0.78
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Translational research (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute on Aging (R01AG033373)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Keywords
- aging, anti-aging drugs, longevity, aging research, rapamycin, resveratrol, aging-related genes, small molecules, drug development, lifespan extension, chronic disease, invertebrate models
- MeSH terms
- Aging, Animals, Gene Expression Regulation, Humans, United States, Translational Research, Biomedical
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
